Desenvolvimento de filmes de quitosana com insulina para liberação controlada de fármaco.

Abstract

Population aging, worldwide phenomenon, is a process that began at birth and changes the lives of individuals and family structures in society. With increasing longevity there is a tendency to the appearance of chronic diseases, such as Diabetes Mellitus, one of the major public health problems today which covers large number of people affected with premature mortality and the costs involved in control treatment of complications and recovery. This study was conducted in order to develop chitosan membranes without neutralization with insulin incorporation for controlled release of the drug. The membranes were developed by the solvent evaporation method and characterized by powder Diffraction X-ray (XRD), spectroscopy in the infrared region Fourier transform (FTIR) spectroscopy, optical microscopy (MO), Scanning Electron Microscopy (SEM), Surface Tension and Swelling. The XRD technique showed that no neutralization of the membrane attributed to a more crystalline same profile when compared to the profile of the chitosan powder, and that both insulin as crosslinking with sodium tripolyphosphate decreased the lens profile of the same. With FTIR test was possible to realize an increase of peak intensity in the regions between 1250 and 1600. Through the OM and SEM techniques it was possible to confirm the presence of insulin encapsulated in the chitosan membranes. In the wetting test, the presence of insulin and crosslinker provided a decrease in wettability compared to the membranes of insulin and chitosan without the crosslinker. Already in the reduction of swelling occurred both as a result of addition of insulin as halftone. The results suggest that insulin was incorporated in the membrane.